314 related articles for article (PubMed ID: 10779217)
1. Helicobacter pylori: criminal or innocent bystander?
Arakawa T; Higuchi K; Fujiwara Y; Tominaga K; Watanabe T; Shiba M; Uchida T; Kuroki T
J Gastroenterol; 2000; 35 Suppl 12():42-6. PubMed ID: 10779217
[TBL] [Abstract][Full Text] [Related]
2. The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti-inflammatory drug use is negligible in southern Europe.
Arroyo MT; Forne M; de Argila CM; Feu F; Arenas J; de la Vega J; Garrigues V; Mora F; Castro M; Bujanda L; Cosme A; Castiella A; Gisbert JP; Hervas A; Lanas A
Helicobacter; 2004 Jun; 9(3):249-54. PubMed ID: 15165261
[TBL] [Abstract][Full Text] [Related]
3. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong.
Xia B; Xia HH; Ma CW; Wong KW; Fung FM; Hui CK; Chan CK; Chan AO; Lai KC; Yuen MF; Wong BC
Aliment Pharmacol Ther; 2005 Aug; 22(3):243-9. PubMed ID: 16091062
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori and non-malignant diseases.
Matysiak-Budnik T; Laszewicz W; Lamarque D; Chaussade S
Helicobacter; 2006 Oct; 11 Suppl 1():27-31. PubMed ID: 16925608
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori and peptic ulcer disease.
Blum AL
Scand J Gastroenterol Suppl; 1996; 214():24-7; discussion 42-3. PubMed ID: 8722401
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori and perforated peptic ulcer prevalence of the infection and role of non-steroidal anti-inflammatory drugs.
Gisbert JP; Legido J; García-Sanz I; Pajares JM
Dig Liver Dis; 2004 Feb; 36(2):116-20. PubMed ID: 15002818
[TBL] [Abstract][Full Text] [Related]
7. Effect of Helicobacter pylori eradication and antisecretory maintenance therapy on peptic ulcer recurrence in cirrhotic patients: a prospective, cohort 2-year follow-up study.
Tzathas C; Triantafyllou K; Mallas E; Triantafyllou G; Ladas SD
J Clin Gastroenterol; 2008 Jul; 42(6):744-9. PubMed ID: 18277886
[TBL] [Abstract][Full Text] [Related]
8. The prevalence of Helicobacter pylori in Japanese children with gastritis or peptic ulcer disease.
Kato S; Nishino Y; Ozawa K; Konno M; Maisawa S; Toyoda S; Tajiri H; Ida S; Fujisawa T; Iinuma K
J Gastroenterol; 2004 Aug; 39(8):734-8. PubMed ID: 15338366
[TBL] [Abstract][Full Text] [Related]
9. Helicobacter pylori infection and the use of NSAIDs.
Bazzoli F; De Luca L; Graham DY
Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):775-85. PubMed ID: 11566040
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori and peptic ulcer disease.
Van der Hulst RW; Tytgat GN
Scand J Gastroenterol Suppl; 1996; 220():10-8. PubMed ID: 8898430
[TBL] [Abstract][Full Text] [Related]
11. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
Asaka M; Kato M; Sugiyama T; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S;
J Gastroenterol; 2003; 38(4):339-47. PubMed ID: 12743773
[TBL] [Abstract][Full Text] [Related]
12. Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial.
de Leest HT; Steen KS; Lems WF; Bijlsma JW; van de Laar MA; Huisman AM; Vonkeman HE; Houben HH; Kadir SW; Kostense PJ; van Tulder MW; Kuipers EJ; Boers M; Dijkmans BA
Helicobacter; 2007 Oct; 12(5):477-85. PubMed ID: 17760715
[TBL] [Abstract][Full Text] [Related]
13. The prevalence of Helicobacter pylori in peptic ulcer disease.
Kuipers EJ; Thijs JC; Festen HP
Aliment Pharmacol Ther; 1995; 9 Suppl 2():59-69. PubMed ID: 8547530
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori-negative peptic ulcers: frequency and implications for management.
Freston JW
J Gastroenterol; 2000; 35 Suppl 12():29-32. PubMed ID: 10779214
[TBL] [Abstract][Full Text] [Related]
15. Management of peptic ulcer disease not related to Helicobacter pylori or NSAIDs.
Quan C; Talley NJ
Am J Gastroenterol; 2002 Dec; 97(12):2950-61. PubMed ID: 12492176
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori-negative peptic ulcer in Japan: which contributes most to peptic ulcer development, Helicobacter pylori, NSAIDS or stress?
Aoyama N; Shinoda Y; Matsushima Y; Shirasaka D; Kinoshita Y; Kasuga M; Chiba T
J Gastroenterol; 2000; 35 Suppl 12():33-7. PubMed ID: 10779215
[TBL] [Abstract][Full Text] [Related]
17. Endoscopic characteristics and Helicobacter pylori infection in NSAID-associated gastric ulcer.
Kamada T; Hata J; Kusunoki H; Sugiu K; Tanimoto T; Mihara M; Hamada H; Kido S; Dongmei Q; Haruma K
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):98-102. PubMed ID: 16706819
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of Helicobacter pylori-induced gastritis and the effect of H. pylori eradication in patients with chronic idiopathic thrombocytopenic purpura.
Ando T; Tsuzuki T; Mizuno T; Minami M; Ina K; Kusugami K; Takamatsu J; Adachi K; El-Omar E; Ohta M; Goto H
Helicobacter; 2004 Oct; 9(5):443-52. PubMed ID: 15361084
[TBL] [Abstract][Full Text] [Related]
19. Non-Helicobacter pylori ulcer disease in rheumatoid arthritis patients receiving long-term NSAID therapy.
Mizokami Y; Narushima K; Shiraishi T; Otsubo T; Narasaka T; Matsuoka T
J Gastroenterol; 2000; 35 Suppl 12():38-41. PubMed ID: 10779216
[TBL] [Abstract][Full Text] [Related]
20. Peptic ulcer disease today.
Yuan Y; Padol IT; Hunt RH
Nat Clin Pract Gastroenterol Hepatol; 2006 Feb; 3(2):80-9. PubMed ID: 16456574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
